Digital biomarker
A smartphone-based diagnostic device for muscle disorders like SMA allows remote monitoring of symptom progression through sensor analysis, enhancing convenience and frequency of assessments, improving treatment efficacy.
Patent Information
- Application Number
- JP2024130521
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-06-19
- Filing Date
- 2024-08-07
- Publication Date
- 2024-11-13
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Current methods for assessing the severity and progression of muscle disorders like spinal muscular atrophy (SMA) require frequent clinical visits, which are costly and inconvenient, limiting the frequency of monitoring and testing.
A diagnostic device and method using a smartphone or wearable sensors to remotely assess distal motor function by prompting subjects to perform tasks, such as crushing tomatoes, and analyzing sensor data to determine symptom severity and progression.
Facilitates frequent and convenient monitoring of muscle disorder symptoms, correlating well with clinical assessments, enabling earlier detection and personalized therapy.
Smart Images

Figure 2024160299000001_ABST
Abstract
Description
[Technical field]
[0001] Field The present invention relates to medical devices for improved subject testing and subject analysis. More particularly, the embodiments described herein provide diagnostic devices, systems and methods for assessing the severity and progression of muscle disorders, in particular spinal muscular atrophy (SMA) symptoms, in a subject by active testing of the subject. [Background technology]
[0002] background Spinal muscular atrophy (SMA), also known as proximal spinal muscular atrophy and 5q spinal muscular atrophy, is an autosomal recessive disease. It is a fatal neuromuscular disorder with low morbidity associated with loss of motor neurons and progressive muscle wasting.
[0003] SMA has become a health problem and a significant economic burden for these health care systems. Because SMA is a clinically heterogeneous disease of the CNS, there is a need for diagnostic tools that allow reliable diagnosis and identification of the current disease state and progression of symptoms, thus aiding in precise treatment.
[0004] There are several standardized methods and tests for measuring the severity and progression of symptoms in subjects diagnosed with SMA. The tests involve a physician measuring the subject's ability to perform physical functions. These standardized tests can provide an assessment of various symptoms, particularly distal motor function, and can help track changes in these symptoms over time. Thus, using standardized methods and tests to assess the severity and progression of symptoms can help guide treatment and therapy options.
[0005] Currently, assessing the severity and progression of symptoms in subjects diagnosed with muscle disorders, particularly SMA, involves monitoring and testing subjects in the clinic every 6 to 12 months (http: / / www.motor-function-measure.org / user-s-manual.aspx, MFM004, MFM017, MFM018, MFM019, MFM020, MFM021, MFM022, MFM-17, 18, 19, 22). While it would be ideal to monitor and test subjects more frequently, increasing the frequency of monitoring and testing in the clinic can be costly and inconvenient for subjects. [Prior art documents] [Non-patent literature]
[0006] [Non-Patent Document 1] http: / / www.motor-function-measure.org / user-s-manual.aspx, MFM004, MFM017, MFM018, MFM019, MFM020, MFM021, MFM022, MFM-17, 18, 19, 22 Summary of the Invention
[0007] Quick Overview The following presents a simplified summary of various aspects described herein. This summary is not an exhaustive summary and is not intended to identify key or critical elements or to define the scope of the claims. The following summary merely presents some concepts in a simplified form as an introductory lead-in to the more detailed description provided below. The aspects described herein describe a specialized medical device for assessing the severity and progression of symptoms for subjects diagnosed with muscle disorders, in particular SMA. Testing and monitoring is performed remotely and outside of a clinic environment, thereby providing lower costs, increased frequency, and simplified ease and convenience for subjects, which may result in improved detection of symptom progression, which in turn may result in better treatment.
[0008] According to one aspect, the present disclosure relates to a diagnostic device for assessing muscle impairment, particularly distal motor function of the SMA, in a subject, the device including at least one processor, one or more sensors associated with the device, and a memory having stored therein computer-readable instructions that, when executed by the at least one processor, cause the device to: receive a first plurality of sensor data via the one or more sensors associated with the device, extract a first plurality of features from the received first sensor data that are associated with muscle impairment, particularly distal motor function of the SMA, in the subject, and determine a first assessment of the muscle impairment, particularly distal motor function of the SMA, based on the extracted first plurality of features.
[0009] 1) A diagnostic device for assessing distal motor function in subjects with muscle disorders, particularly SMA, comprising: At least one processor; one or more sensors associated with the device; A memory having computer readable instructions stored thereon, The computer readable instructions, when executed by the at least one processor, cause the device to: receiving a first plurality of sensor data via the one or more sensors associated with the device; extracting a first plurality of features from the received first sensor data that are related to a muscle disorder, in particular the distal motor function of a subject with SMA; determining a first assessment of the subject's distal motor function based on the first plurality of extracted features; and To carry out a memory storing said computer readable instructions; A device comprising:
[0010] 2) the computer-readable instructions, when executed by the at least one processor, cause the device to: prompting the subject to perform a diagnostic task of crushing as many tomatoes as possible by pinching them between the thumb and index finger of the same hand during a 30 second period; receiving a plurality of second sensor data via the one or more sensors associated with the device in response to the subject performing the diagnostic task; extracting a second plurality of features related to the distal motor function of the subject from the received second sensor data; determining a second assessment of the subject's distal motor function based on the extracted second plurality of features; and The device of E1, further comprising:
[0011] 3) The device according to E1 or 2, which is a smartphone.
[0012] 4) A device described in any one of E1 to E3, wherein the diagnostic task is associated with at least one of muscle function tests.
[0013] 5) A computer-implemented method for assessing distal motor function in a subject with a muscle disorder, in particular, SMA, comprising: Receiving a first plurality of sensor data via one or more sensors associated with the device; extracting a first plurality of features from the received first sensor data that are related to a muscle disorder, in particular the distal motor function of a subject with SMA; determining a first assessment of the distal motor function of the subject with a muscle disorder, in particular SMA, based on the first plurality of extracted features; 4. A computer-implemented method comprising:
[0014] 6) prompting the subject to perform one or more diagnostic tasks; and receiving a plurality of second sensor data via the one or more sensors in response to the subject performing the one or more diagnostic tasks; extracting a second plurality of features from the received second sensor data related to a muscle impairment, in particular the distal motor function of the subject with SMA; determining a second assessment of the distal motor function of the subject with a muscle impairment, in particular SMA, based on at least the extracted second sensor data; The computer-implemented method of E5, further comprising:
[0015] 7) The computer-implemented method of E5 or 6, wherein the subject's distal motor function is assessed based on an active task, in particular based on the amount of crushed tomato obtained by pinching a tomato between the thumb and index finger of the same hand during a 30 second period.
[0016] 8) The device described in any one of E1 to E4 or the computer-implemented method described in any one of claims 5 to 7, wherein the subject is a human being.
[0017] 9) A non-transitory machine-readable storage medium comprising machine-readable instructions for causing a processor to perform a method for assessing distal motor function in a subject with a muscle disorder, in particular, SMA, comprising: The method further comprising: receiving a plurality of sensor data via one or more sensors associated with the device; extracting from the received sensor data a number of features related to a muscle impairment, in particular the distal motor function of a subject with SMA; determining an assessment of the distal motor function of the subject with a muscle disorder, in particular SMA, based on the extracted features; Including, A non-transitory machine-readable storage medium.
[0018] 10) A method for assessing muscle disorders, particularly SMA, in a subject, comprising: determining a usage behavior parameter from a dataset comprising usage data of a device according to any one of claims 1 to 5 within a first predefined time window during which the device was used by the subject; comparing the determined at least one usage behavior parameter with a standard, whereby the subject with a muscle disorder, in particular SMA, is evaluated; and A method comprising:
[0019] 11) A method for identifying a subject as having a muscle disorder, in particular SMA, comprising: i) scoring subjects on a diagnostic task of crushing as many tomatoes as possible by pinching them between the thumb and index finger of the same hand during a 30 second period; ii) comparing the determined score with a standard, whereby a muscle disorder, in particular SMA, is assessed; and A method comprising:
[0020] 12) administering to the subject a medicament active agent to reduce the likelihood of progression of muscle disorders, in particular SMA, in which the medicament active agent is suitable for treating SMA in the subject, in particular a m7GpppX diphosphatase (DCPS) inhibitor, a survival motor neuron protein 1 regulator, an SMN2 expression inhibitor, an SMN2 splicing regulator, an SMN2 expression enhancer, a survival motor neuron protein 2 regulator, or an SMN-AS1 (SMN1-derived long non-coding RNA) inhibitor, more specifically nusinersen, onasemnogene abeparvovec, risdiplam, or branapram. The method of E11, further comprising:
[0021] 13) The combination of methods according to E12, wherein at least one determined parameter is more favorable compared to a baseline parameter of the patient before the subject was treated with the pharmaceutical agent.
[0022] 14) The method according to E12 or 13, wherein the subject is a human being.
[0023] 15) The method according to any one of E12 to E14, wherein the drug is risdiplam. [Brief description of the drawings]
[0024] A more complete understanding of the aspects described herein and their advantages may be obtained by reference to the following description in consideration of the accompanying drawings, in which like reference numerals indicate like features and in which:
[0025] [Figure 1] FIG. 1 illustrates an exemplary environment in which a diagnostic device for assessing muscle disorders, and in particular distal motor function of the SMA, in a subject is provided according to an exemplary embodiment. [Diagram 2] 1 is a flow diagram of a method for assessing muscle impairment, in particular distal motor function of the SMA, in a subject based on active testing of the subject according to an exemplary embodiment. [Diagram 3] FIG. 1 illustrates an example of a network architecture and data processing devices that may be used to implement one or more exemplary aspects described herein. [Figure 4] FIG. 1 illustrates an example illustrating a diagnostic application according to one or more exemplary aspects described herein. [Diagram 5] 1 is a plot showing sensor characterization results according to Example 1. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0026] Detailed Description In the following description of various aspects, reference is made to the accompanying drawings, which form a part hereof, and which show, by way of example, various embodiments in which the aspects described herein may be practiced. It is to be understood that other aspects and / or embodiments may be utilized, and structural and functional changes may be made without departing from the scope of the described aspects and embodiments. The aspects described herein are capable of other embodiments and of being practiced or carried out in various ways. It is also to be understood that the phraseology and terminology used herein are for purposes of description and should not be considered as limiting. Rather, the phrases and terms used herein are to be given their broadest interpretation and meaning. The use of "including" and "comprising" and variations thereof are intended to encompass the items described thereafter and their equivalents, as well as additional items and their equivalents. The use of the terms "mounted," "connected," "coupled," "disposed," "engaged," and similar terms are intended to encompass both direct and indirect mounting, connecting, coupling, disposing, engaging.
[0027] The systems, methods and devices described herein provide diagnostics for assessing muscle disorders, particularly distal motor function of the SMA, in a subject. In some embodiments, the diagnostics can be provided to the subject as a software application installed on a mobile device, particularly a smartphone.
[0028] In some embodiments, when the subject performs activities of daily living, the diagnostic acquires or receives sensor data from one or more sensors associated with a mobile device. In some embodiments, the sensor may be in a mobile device such as a smartphone or a wearable sensor such as a smartwatch. In some embodiments, sensor features related to muscle disorders, particularly symptoms of SMA, are extracted from the received or acquired sensor data. In some embodiments, an assessment of the severity and progression of muscle disorders, particularly symptoms of SMA, in the subject is determined based on the extracted sensor features.
[0029] In some embodiments, the systems, methods and devices according to the present disclosure provide a diagnosis for assessing muscle impairment, particularly SMA, in a subject based on active testing of the subject. In some embodiments, the diagnosis prompts the subject to perform a diagnostic task. In some embodiments, the diagnostic task is anchored or subsequently modeled in established methods and standardized tests. In some embodiments, in response to the subject performing the diagnostic task, the diagnosis acquires or receives sensor data via one or more sensors. In some embodiments, the sensor may be in a mobile device or a wearable sensor worn by the subject. In some embodiments, sensor features related to muscle impairment, particularly SMA symptoms, are extracted from the received or acquired sensor data. In some embodiments, an assessment of the severity and progression of muscle impairment, particularly SMA symptoms, in the subject is determined based on the extracted features of the sensor data.
[0030] The evaluation of the severity and progression of symptoms of muscle disorders, particularly SMA, using the diagnosis according to the present disclosure correlates well with the evaluation based on clinical outcomes, and therefore can replace clinical subject monitoring and testing. The exemplary diagnosis according to the present disclosure can be used outside of a clinic environment, and therefore has advantages in terms of cost, ease of subject monitoring, and subject convenience. This facilitates frequent, particularly daily, subject monitoring and testing, produces a better understanding of disease stages, and gives insights into the disease that are useful to both the clinical and research communities. The exemplary diagnosis according to the present disclosure can provide earlier detection of even small changes in distal motor function of muscle disorders, particularly SMA, in subjects, and therefore can be used for better disease management, including personalized therapy.
[0031] FIG. 1 is a diagram of an exemplary environment in which a diagnostic device 105 for assessing muscle impairments, particularly distal motor function of the SMA, in a subject 110 is provided. In some embodiments, the device 105 may be a smartphone, smartwatch, or other mobile computing device. The device 105 includes a display screen 160. In some embodiments, the display screen 160 may be a touch screen. The device 105 includes at least one processor 115 and a memory 125 that stores computer instructions for a symptom monitoring application 130 that, when executed by the at least one processor 115, causes the device 105 to assess muscle impairments, particularly distal motor function of the SMA. The device 105 receives a plurality of sensor data via one or more sensors associated with the device 105. In some embodiments, the one or more sensors associated with the device are at least one of sensors disposed within the device or worn by the subject and configured to communicate with the device. 1, sensors associated with device 105 include a first sensor 120a disposed within device 105 and a second sensor 120b that may be worn by subject 110. Device 105 receives a plurality of first sensor data via first sensor 120a and a plurality of second sensor data via second sensor 120b as subject 110 performs an activity.
[0032] The device 105 extracts features related to muscle disorders, particularly distal motor function of the SMA, in the subject 110 from the received first and second sensor data. In some embodiments, symptoms of muscle disorders, particularly SMA, in the subject 110 may include symptoms indicative of distal motor function of the subject 110 and symptoms indicative of distal motor function of the subject 110.
[0033] In some embodiments, the sensors 120 associated with the device 105 may include sensors associated with Bluetooth and WiFi functionality, and the sensor data may include information related to Bluetooth and WiFi signals received by the sensors 120. In some embodiments, the device 105 extracts data from the received first and second sensor data corresponding to the density of Bluetooth and WiFi signals received or transmitted by the device 105 or the sensors. In some embodiments, an assessment of the subject's 110 distal motor function may be based on the extracted Bluetooth and WiFi signal data (e.g., an assessment of the subject's sociability may be based in part on the density of picked up Bluetooth and WiFi signals).
[0034] The device 105 determines an assessment of the muscle impairment, particularly the distal motor function of the SMA, in the subject 110 based on the extracted features of the received first and second sensor data. In some embodiments, the device 105 sends the extracted features over the network 180 to the server 150. The server 150 includes at least one processor 155 and a memory 161 that stores computer instructions for a symptom assessment application 170 that, when executed by the server processor 155, causes the processor 155 to determine an assessment of the muscle impairment, particularly the distal motor function of the SMA, in the subject 110 based on the extracted features received by the server 150 from the device 105. In some embodiments, the symptom assessment application 170 may determine an assessment of the muscle impairment, particularly the distal motor function of the SMA, in the subject 110 based on the extracted features of the sensor data received from the device 105 and a subject database 175 stored in the memory 160. In some embodiments, the subject database 175 may include subject and / or clinical data. In some embodiments, the subject database 175 may include clinic sensor-based measurements of distal motor function at baseline and over time from subjects with muscle impairments, particularly SMA. In some embodiments, the subject database 175 may be independent of the server 150. In some embodiments, the server 150 sends the determined assessment of muscle impairments, particularly SMA distal motor function, in the subject 110 to the device 105. In some embodiments, the device 105 may output the assessment of muscle impairments, particularly SMA distal motor function. In some embodiments, the device 105 may communicate information to the subject 110 based on the assessment. In some embodiments, the assessment of muscle impairments, particularly SMA distal motor function, may be communicated to a clinician who may determine an individualized therapy for the subject 110 based on the assessment.
[0035] In some embodiments, the computer instructions for the symptom monitoring application 130, when executed by the at least one processor 115, cause the device 105 to assess muscle impairments, particularly distal motor function of the SMA, in the subject 110 based on active testing of the subject 110. The device 105 prompts the subject 110 to perform one or more tasks. In some embodiments, prompting the subject to perform one or more diagnostic tasks includes prompting the subject to transcribe a pre-specified sentence or prompting the subject to perform one or more actions. In some embodiments, the diagnostic tasks are anchored in or modeled after established methods and standardized tests for assessing and evaluating muscle impairments, particularly the SMA.
[0036] According to embodiments disclosed herein, the sensor may be, for example, a motion sensor.
[0037] In response to the subject 110 performing one or more diagnostic tasks, the diagnostic device 105 receives a plurality of sensor data via one or more sensors associated with the device 105. As described above, the sensors associated with the device 105 may include a first sensor 120a disposed within the device 105 and a second sensor 120b worn by the subject 110. The device 105 receives a plurality of first sensor data via the first sensor 120a and a plurality of second sensor data via the second sensor 120b. In some embodiments, the one or more diagnostic tasks may be associated with measuring distal motor function, in particular measuring the time difference between the fingers touching the glass (double touch asynchrony) when performing the task.
[0038] The device 105 extracts features related to muscle disorders, particularly distal motor function of the SMA, in the subject 110 from the received plurality of first sensor data and the received plurality of second sensor data. Symptoms of muscle disorders, particularly SMA, in the subject 110 may include symptoms indicative of distal motor function of the subject 110.
[0039] The device 105 determines an assessment of the muscle impairment, particularly the distal motor function of the SMA, in the subject 110 based on the extracted features of the received first and second sensor data. In some embodiments, the device 105 sends the extracted features over the network 180 to the server 150. The server 150 may include at least one processor 155 and a memory 161 storing computer instructions for a symptom assessment application 170 that, when executed by the server processor 155, causes the processor 155 to determine an assessment of the muscle impairment, particularly the distal motor function of the SMA, in the subject 110 based on the extracted features received by the server 150 from the device 105. In some embodiments, the symptom assessment application 170 may determine an assessment of the muscle impairment, particularly the distal motor function of the SMA, in the subject 110 based on the extracted features of the sensor data received from the device 105 and a subject database 175 stored in the memory 160. In some embodiments, the subject database 175 may include subject and / or clinical data. In some embodiments, the subject database 175 may include measurements of distal motor function at baseline and over time from subjects with muscle disorders, particularly SMA. In some embodiments, the subject database 175 may include data from subjects at other stages of muscle disorders, particularly SMA. In some embodiments, the subject database 175 may be independent of the server 150. In some embodiments, the server 150 sends the determined assessment of the muscle disorder, particularly SMA distal motor function in the subject 110 to the device 105. In some embodiments, the device 105 may output the assessment of the muscle disorder, particularly SMA distal motor function. In some embodiments, the device 105 may communicate information to the subject 110 based on the assessment. In some embodiments, the assessment of the muscle disorder, particularly SMA distal motor function may be communicated to a clinician who may determine an individualized therapy for the subject 110 based on the assessment.
[0040] FIG. 2 illustrates an exemplary method for assessing muscle impairments, particularly distal motor function of the SMA, in a subject based on active testing of the subject using the exemplary device 105 of FIG. 1. FIG. 3 is described with reference to FIG. 1, but it should be noted that the method steps of FIG. 3 may be performed by other systems. The method includes prompting the subject to perform one or more diagnostic tasks (205). The method includes receiving a plurality of sensor data via one or more sensors in response to the subject performing the one or more tasks (step 210). The method includes extracting a plurality of features related to the muscle impairments, particularly distal motor function of the SMA, from the received sensor data (215). The method includes determining an assessment of the muscle impairments, particularly distal motor function of the SMA, based at least on the extracted sensor data (step 220).
[0041] 2 illustrates an exemplary method for assessing muscle impairment, and in particular distal motor function of the SMA, based on active testing of a subject 110 using the exemplary device 105 in FIG 1. In some embodiments, active testing of a subject 110 using the device 105 may be selected via a user interface of a symptom monitoring application 130.
[0042] The method begins by proceeding to step 205, which includes prompting the subject 110 to perform a diagnostic task. The device 105 prompts the subject 110 to perform one or more diagnostic tasks. In some embodiments, prompting the subject to perform one or more diagnostic tasks includes prompting the subject to perform one or more actions. In some embodiments, the diagnostic tasks are anchored in or subsequently modeled after established methods and standardized tests for assessing and evaluating muscle disorders, particularly SMA.
[0043] In some embodiments, a diagnostic task may involve squashing a tomato as often as possible within 30 seconds.
[0044] The term "test" as used herein describes a test in which a subject is asked to perform a diagnostic task as described herein.
[0045] The method proceeds to step 210, which includes receiving a plurality of second sensor data via one or more sensors in response to the subject performing one or more diagnostic tasks. In response to the subject 110 performing one or more diagnostic tasks, the diagnostic device 105 receives a plurality of sensor data via one or more sensors associated with the device 105. As described above, the sensors associated with the device 105 include a first sensor 120a disposed within the device 105 and a second sensor 120b worn by the subject 110. The device 105 receives a plurality of first sensor data via the first sensor 120a and a plurality of second sensor data via the second sensor 120b.
[0046] The method proceeds to step 215, which includes extracting a second plurality of features from the received sensor data related to muscle impairment, particularly distal motor function of the SMA. The device 105 extracts features from the received first and second sensor data related to muscle impairment, particularly distal motor function of the SMA, in the subject 110. The symptoms of muscle impairment, particularly SMA, in the subject 110 may include symptoms indicative of distal motor function of the subject 110. In some embodiments, the extracted features of the plurality of first and second sensor data may be indicative of muscle impairment, particularly SMA symptoms, such as distal motor function.
[0047] The method proceeds to step 220, which includes determining an assessment of the muscle impairment, particularly the distal motor function of the SMA, based on at least the extracted sensor data. The device 105 determines an assessment of the muscle impairment, particularly the distal motor function of the SMA, in the subject 110 based on the extracted features of the received first and second sensor data. In some embodiments, the device 105 may send the extracted features to the server 150 via the network 180. The server 150 includes at least one processor 155 and a memory 160 that stores computer instructions for a symptom assessment application 170 that, when executed by the processor 155, determines an assessment of the muscle impairment, particularly the distal motor function of the SMA, in the subject 110 based on the extracted features received by the server 150 from the device 105. In some embodiments, the symptom assessment application 170 may determine an assessment of the muscle impairment, particularly the distal motor function of the SMA, in the subject 110 based on the extracted features of the sensor data received from the device 105 and a subject database 175 stored in the memory 160. The subject database 175 may include various clinical data. In some embodiments, the second device may be one or more wearable sensors. In some embodiments, the second device may be any device including a motion sensor with an inertial measurement unit (IMU). In some embodiments, the second device may be several devices or sensors. In some embodiments, the subject database 175 may be independent of the server 150. In some embodiments, the server 150 sends the determined assessment of the muscle impairment, particularly the distal motor function of the SMA, in the subject 110 to the device 105. In some embodiments, such as FIG. 1, the device 105 may output the assessment of the muscle impairment, particularly the distal motor function of the SMA, on the display 160 of the device 105.
[0048] As explained above, the assessment of the severity and progression of symptoms of muscle disorders, particularly SMA, using the diagnosis according to the present disclosure correlates well with clinical outcome-based assessments and may therefore replace clinical subject monitoring and testing. The diagnosis according to the present disclosure was studied in a group of subjects with muscle disorders, particularly SMA subjects. The subjects were provided with a smartphone application that included distal motor function tests, particularly a test called "Smash a Tomato".
[0049] FIG. 3 illustrates an example of a network architecture and data processing devices that may be used to implement one or more exemplary aspects described herein, such as those described in FIG. 1 and FIG. 2. Various network nodes 303, 305, 307, and 309 may be interconnected via a wide area network (WAN) 301, such as the Internet. Other networks, including private intranets, corporate networks, LANs, wireless networks, personal networks (PANs), and the like, may also or alternatively be used. Network 301 is for illustrative purposes and may be replaced with fewer or additional computer networks. Local area networks (LANs) may have one or more of any known LAN topologies and may use one or more of a wide variety of protocols, such as Ethernet. Devices 303, 305, 307, 309 and other devices (not shown) may be connected to one or more of the networks via twisted pair wires, coaxial cables, optical fibers, radio waves, or other communication media.
[0050] The term "network" as used herein and shown in the drawings refers not only to a system in which remote storage devices are coupled to one another via one or more communication paths, but also to stand-alone devices that may be coupled from time to time to such a system having storage capacity. Thus, the term "network" not only includes a "physical network," but also includes a "content network" that is comprised of data originating from a single entity that resides across all physical networks.
[0051] The components may include a data server 303, a web server 305, and client computers 307, 309. The data server 303 provides overall access, control, and management of the databases and control software for implementing one or more exemplary embodiments described herein. The data server 303 may be connected to a web server 305 through which users interact with and obtain requested data. Alternatively, the data server 303 may itself act as a web server and be connected directly to the Internet. The data server 303 may be connected to the web server 305 through a network 301 (e.g., the Internet) via a direct or indirect connection or through some other network. Users may interact with the data server 303 using remote computers 307, 309, for example, using a web browser to connect to the data server 303 via one or more externally exposed websites hosted by the web server 305. The client computers 307, 309 may be used in cooperation with the data server 303 to access data stored therein, or may be used for other purposes. For example, from a client device 307, a user may access the web server 305 using an Internet browser, as known in the art, or by executing a software application that communicates with the web server 305 and / or the data server 303 over a computer network (such as the Internet). In some embodiments, the client computer 307 may be a smartphone, smartwatch, or other mobile computing device and may implement a diagnostic device, such as device 105 shown in FIG. 1. In some embodiments, the data server 303 may implement a server, such as server 150 shown in FIG. 1.
[0052] Servers and applications may be combined on the same physical machine and maintain separate virtual or logical addresses, or may reside on separate physical machines. Figure 1 shows just one example of a network architecture that may be used, and those skilled in the art will appreciate that the particular network architecture and data processing devices used may vary and are secondary to the functions they provide, as further described herein. For example, the services provided by web server 305 and data server 303 may be combined on a single server.
[0053] Each of the components 303, 305, 307, 309 may be any type of known computer, server, or data processing device. The data server 303 may include, for example, a processor 311 that controls the overall operation of the rate server 303. The data server 303 may further include a RAM 313, a ROM 315, a network interface 317, an input / output interface 319 (e.g., keyboard, mouse, display, printer, etc.), and a memory 321. The input / output 319 may include various interface units and drives for reading, writing, displaying, and / or printing data or files. The memory 321 may further store operating system software 323 for controlling the overall operation of the data processing device 303, control logic 325 for instructing the data server 303 to perform aspects described herein, and other application software 327 that provides secondary, support, and / or other functions that may or may not be used in conjunction with other aspects described herein. The control logic may also be referred to herein as data server software 325. The functionality of the data server software may refer to a combination of actions or decisions taken automatically based on rules coded into the control logic, actions or decisions taken manually by a user providing input to the system, and / or automated processing based on user input (e.g., queries, data updates, etc.).
[0054] The memory 321 may also store data used in the execution of one or more aspects described herein, including a first database 329 and a second database 331. In some embodiments, the first database may include a second database (e.g., as a separate table, report, etc.). That is, the information may be stored in a single database or separated into different logical, virtual, or physical databases, depending on the system design. The devices 305, 307, 309 may have an architecture similar to or different from that described with respect to the device 303. Those skilled in the art will appreciate that the functionality of the data processing device 303 (or devices 305, 307, 309) described herein may be spread across multiple data processing devices, for example, to distribute the processing load across multiple computers, to segregate transactions based on geographic location, user access level, quality of service (QoS), etc.
[0055] One or more aspects described herein may be embodied in computer usable or readable data and / or computer executable instructions, such as in one or more program modules, executed by one or more computers or other devices as described herein. Generally, a program module includes routines, programs, objects, components, data structures, etc., that perform particular tasks or implement particular abstract data types when executed by a processor in a computer or other device. The modules may be written in a source code programming language that is subsequently compiled for execution, or in a scripting language, such as (but not limited to) HTML or XML. The computer executable instructions may be stored on a computer readable medium, such as a hard disk, an optical disk, a removable storage medium, a solid-state memory, a RAM, etc. As will be appreciated by those skilled in the art, the functionality of the program modules may be combined or distributed as desired in various embodiments. Furthermore, the functionality may be embedded, in whole or in part, in firmware or hardware equivalents, such as integrated circuits, field programmable gate arrays (FPGAs), etc. Particular data structures may be used to more effectively implement one or more aspects, and such data structures are contemplated within the scope of the computer-executable instructions and computer-usable data described herein.
[0056] 4 illustrates an example illustrating a diagnostic test according to one or more exemplary aspects described herein. The user must select "Start" to begin with the task.
[0057] Figure 5 is a plot showing sensor signature results from the Example 3 "Squash a Tomato" diagnostic test shown in Figures 5A-5B. The sensor signature (time difference between finger touching screen in seconds) results match the clinical anchors in both studies (average of MFM004, MFM017, MFM018, MFM019, MFM020, MFM021, MFM022).
[0058] Although the subject matter has been described in language specific to structural features and / or methodological acts, it is to be understood that the subject matter defined in the appended claims is not necessarily limited to the specific features or acts described above. Rather, the specific features and acts described above are disclosed as example forms of implementing the claims. EXAMPLES
[0059] Example 1 Patient characteristics of the analyzed groups collected during two different studies. i) OLEOS study (https: / / clinicaltrials.gov / ct2 / show / NCT02628743) Participants analyzed: 20 Time period for data analysis: Smartphone data during the last two clinical visits (176 days) TIFF2024160299000002.tif35128ii) JEWELFISH study (https: / / clinicaltrials.gov / ct2 / show / NCT03032172?term=BP39054) Participants analyzed: 19 TIFF2024160299000003.tif35128
[0060] Collection of a dataset using a distal motor function test, a computer-implemented test (Test: Squash a Tomato) to determine the synchronicity of two fingers (a punch finger and an index finger of the same hand) by measuring the delay between the first and second finger touching the screen for all detected double touches TIFF2024160299000004.tif234152TIFF2024160299000005.tif41152Covariates:1: MFM-17, 18, 19, 22.2: Mean of MFM004, MFM017, MFM018, MFM019, MFM020, MFM021, MFM022.3: Sum of 32 = total score of MFM.4: MFM-17. ICC: intraclass correlation coefficient. DTA: double touch asynchrony. P_GA: pinch gap duration. SD=standard deviation.
[0061] The test for double touch asynchrony (DTA) was implemented on a mobile phone (iPhone). The patient shall crush as many tomatoes as possible within 30 seconds by pinching them between the thumb and index finger of the indicated hand. The phone has to be placed on the table. The referred hand has to be selected. The patient has to play the game for 30 seconds.
[0062] Figure 5 shows the correlation between the clinical anchor test and the results from the Squish Tomato test (DTA). The sensor feature results are consistent with the clinical anchors in both studies.
Claims
1. 1. A diagnostic device for assessing distal motor function in a subject with a muscle disorder, in particular SMA, comprising: At least one processor; one or more sensors associated with the device; A memory having computer readable instructions stored thereon, The computer readable instructions, when executed by the at least one processor, cause the device to: receiving a first plurality of sensor data via the one or more sensors associated with the device; extracting from the received schi data a first plurality of features related to the distal motor function of a subject with a muscle disorder, in particular SMA; determining a first assessment of the subject's distal motor function based on the extracted first plurality of features; To carry out a memory storing said computer readable instructions; A device comprising:
2. The computer readable instructions, when executed by the at least one processor, cause the device to: prompting the subject to perform a diagnostic task of crushing as many tomatoes as possible by pinching them between the thumb and index finger of the same hand during a 30 second period; receiving a plurality of second sensor data via the one or more sensors associated with the device in response to the subject performing the diagnostic task; extracting a second plurality of features related to the distal motor function of the subject from the received second sensor data; determining a second assessment of the subject's distal motor function based on the extracted second plurality of features; and The device of claim 1 , further comprising:
3. The device according to claim 1 or 2, which is a smartphone.
4. The device according to any one of claims 1 to 3, wherein the diagnostic task is associated with at least one of muscle function tests.
5. 1. A computer-implemented method for assessing distal motor function in a subject with a muscle disorder, in particular SMA, comprising: receiving a first plurality of sensor data via one or more sensors associated with the device; extracting a first plurality of features from the received first sensor data that are related to the distal motor function of a subject with a muscle disorder, in particular SMA; determining a first assessment of the distal motor function of the subject with a muscle disorder, in particular SMA, based on the first plurality of extracted features; 4. A computer-implemented method comprising:
6. Prompting the subject to perform one or more diagnostic tasks; receiving a plurality of second sensor data via the one or more sensors in response to the subject performing the one or more diagnostic tasks; extracting a second plurality of features from the received second sensor data related to the distal motor function of a subject with a muscle disorder, in particular SMA; determining a second assessment of the distal motor function of the subject with a muscle impairment, in particular SMA, based on at least the extracted second sensor data; The computer-implemented method of claim 5 , further comprising:
7. 7. The computer-implemented method according to claim 5 or 6, wherein the subject's distal motor function is assessed on the basis of an active task, in particular on the amount of crushed tomatoes obtained by pinching a tomato between the thumb and index finger of the same hand during a period of 30 seconds.
8. A device according to any one of claims 1 to 4 or a computer-implemented method according to any one of claims 5 to 7, wherein the subject is a human being.
9. 1. A non-transitory machine-readable storage medium comprising machine-readable instructions for causing a processor to perform a method for assessing distal motor function in a subject with a muscle disorder, in particular SMA, the method comprising: The method further comprising: receiving a plurality of sensor data via one or more sensors associated with the device; extracting from the received sensor data a number of features related to the distal motor function of a subject with a muscle disorder, in particular SMA; determining an assessment of the distal motor function of the subject with a muscle disorder, in particular SMA, based on the extracted features; Including, A non-transitory machine-readable storage medium.
10. 1. A method for assessing muscle disorders, particularly SMA, in a subject, comprising: - determining a usage behavioural parameter from a dataset comprising usage data of a device according to any one of claims 1 to 5 within a first predefined time window during which the device was used by the subject; comparing the determined at least one usage behavior parameter with a reference, whereby the subject with a muscle disorder, in particular SMA, is evaluated; A method comprising:
11. 1. A method for identifying a subject as having a muscle disorder, in particular SMA, comprising: i) scoring subjects on a diagnostic task of crushing as many tomatoes as possible by pinching them between the thumb and index finger of the same hand during a 30 second period; ii) comparing said determined score with a standard, whereby a muscle disorder, in particular SMA, is assessed; and A method comprising:
12. administering to said subject a medicament active agent to reduce the likelihood of progression of muscle disorders, in particular SMA, in particular said medicament active agent being suitable for treating SMA in a subject, in particular a m7GpppX diphosphatase (DCPS) inhibitor, a survival motor neuron protein 1 modulator, an SMN2 expression inhibitor, an SMN2 splicing modulator, an SMN2 expression enhancer, a survival motor neuron protein 2 modulator, or an SMN-AS1 (SMN1-derived long non-coding RNA) inhibitor, more particularly nusinersen, onasemnogene abeparvovec, risdiplam, or branapram. The method of claim 11 further comprising:
13. 13. The method of claim 12, wherein at least one determined parameter is more favorable compared to a patient's baseline parameter before the subject was treated with the pharmaceutical agent.
14. The method of claim 12 or 13, wherein the subject is a human.
15. The method of any one of claims 12 to 14, wherein the drug is risdiplam.
Citation Information
Patent Citations
Diagnosis and treatment of movement disorders
JP2017500962A
Task execution sequence determination system and task execution method
JP2018051003A
System and Method for Monitoring Respiratory Rate and Oxygen Saturation
US20190015014A1
Method for setting difficulty level of training contents and electronic device implementing the same
US20190175989A1
Use of myostatin inhibitors and combination therapies
WO2017218592A1
